@sigtrans-sttt.bsky.socialAdvanced #SCLC requires innovative therapeutic strategies beyond standard #Chemoradiotherapy.
A randomized trial reports improved progression-free and overall survival with camrelizumab-based induction and consolidation therapy.
@theinnovation.bsky.socialThis study combines dynamic exhaled VOC profiling with clinical features to predict chemoradiotherapy efficacy and survival outcomes in esophageal squamous cell carcinoma, offering a novel non-invasive strategy for personalized cancer treatment.
doi.org/10.59717/j.x...
#Chemoradiotherapy #Cancer
